Luminex to Seek Slice of Newborn Screening Market This Year

Luminex will be going after a piece of the newborn screening market, estimated to be a $100 million-plus opportunity, with a new assay slated for an initial launch in Europe later this year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.